MADELINE GRESHAM: Open Payments
NPI 1124748009 · PEKIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 15 payments from 10 companies in 2025. Trend: 2023 $209 · 2024 $1,685 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $149 |
| Organon LLC | 2 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| Biogen, Inc. | 2 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Boston Scientific Corporation | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Exeltis, USA Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $16 |
| Hologic Sales and Service, LLC | 1 | $16 |
Products named: EVENITY, NEXPLANON, Mirena, ZURZUVAE, JOURNAVX, Solyx SIS System, Veozah, SLYND.
Industry payments across IL — which companies pay providers there.
